Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Student development evening

By Karen Loudon / August 16, 2018
A student development evening was held on 13 August 2018 at Monash University Clayton where Professor Graham Jenkin a represented Cartherics...
Read More

Eradicate Cancer Conference 2108

By carth_admin / July 12, 2018
Our organising committee has been working relentlessly on this inaugural world conference having now assembled an excellent program of 40+...
Read More